Deep EigenMatics Ranks #1 Globally in AI Drug Discovery, Outpacing All of Big Pharma in 2025 Patent Output
PR Newswire —
Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S....